Schubiger PA - Search Results

1

[123I/125I]-Ro 43-0463, a site specific tracer for MAO-B mapping with autoradiography as well as with SPET.

Beer HF, Frey LD, Rossetti I, Remy N, Maier A, Schubiger PA. Beer HF, et al. Among authors: schubiger pa. J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):581-93. doi: 10.3109/10799899509045241. J Recept Signal Transduct Res. 1995. PMID: 8903965

2

Biodistribution and estimated radiation burden for a new 123I-labelled monoamine oxidase-B inhibitor, Ro 43-0463: a preliminary report.

Hasler PH, Beer HF, Frey L, Rossetti I, Schubiger PA. Hasler PH, et al. Among authors: schubiger pa. J Nucl Biol Med (1991). 1994 Dec;38(4 Suppl 1):59-62. J Nucl Biol Med (1991). 1994. PMID: 7632769

3

In vitro and in vivo testing of the dopamine D1 ligand [123I]SCH 23982 with respect to its potential application in SPET investigations.

Beer HF, Lin S, Bläuenstein P, Hasler P, Schubiger PA, Maier A, Lichtensteiger W, Oettli R, Bekier A, Weder B. Beer HF, et al. Among authors: schubiger pa. Nucl Med Biol. 1993 Jul;20(5):607-16. doi: 10.1016/0969-8051(93)90029-t. Nucl Med Biol. 1993. PMID: 8358346

4

123I-labeling and evaluation of Ro 43-0463, a SPET tracer for MAO-B imaging.

Beer HF, Rossetti I, Frey LD, Hasler PH, Schubiger PA. Beer HF, et al. Among authors: schubiger pa. Nucl Med Biol. 1995 Oct;22(7):929-936. doi: 10.1016/0969-8051(95)00041-u. Nucl Med Biol. 1995. PMID: 8547891

5

[123I/18F] N-(2-aminoethyl)-5-halogeno-2-pyridinecarbox-amides, site specific tracers for MAO-B mapping with SPECT and PET.

Beer HF, Frey LD, Häberli M, Schubiger PA. Beer HF, et al. Among authors: schubiger pa. Nucl Med Biol. 1995 Nov;22(8):999-1004. doi: 10.1016/0969-8051(95)02022-5. Nucl Med Biol. 1995. PMID: 8998478 Clinical Trial.

6

In vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B.

Bläuenstein P, Rémy N, Buck A, Ametamey S, Häberli M, Schubiger PA. Bläuenstein P, et al. Among authors: schubiger pa. Nucl Med Biol. 1998 Jan;25(1):47-52. doi: 10.1016/s0969-8051(97)00143-1. Nucl Med Biol. 1998. PMID: 9466361

7

Large scale preparation strategy for labelling of [123I]-SCH 23982, a dopamine D1 receptor binding agent.

Beer HF, Lin S, Novak-Hofer I, Bläuenstein P, Schubiger PA. Beer HF, et al. Among authors: schubiger pa. Int J Rad Appl Instrum A. 1992 Jun;43(6):781-7. doi: 10.1016/0883-2889(92)90242-7. Int J Rad Appl Instrum A. 1992. PMID: 1319421

8

Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.

Ametamey SM, Beer HF, Guenther I, Antonini A, Leenders KL, Waldmeier PC, Schubiger PA. Ametamey SM, et al. Among authors: schubiger pa. Nucl Med Biol. 1996 Apr;23(3):229-34. doi: 10.1016/0969-8051(95)02051-9. Nucl Med Biol. 1996. PMID: 8782230

9

Monoamine oxidase B single-photon emission tomography with [123I]Ro 43-0463: imaging in volunteers and patients with temporal lobe epilepsy.

Buck A, Frey LD, Bläuenstein P, Krämer G, Siegel A, Weber B, Schubiger PA, Wieser HG. Buck A, et al. Among authors: schubiger pa. Eur J Nucl Med. 1998 May;25(5):464-70. doi: 10.1007/s002590050245. Eur J Nucl Med. 1998. PMID: 9575241

10

123I-SCH 23982 is not suitable for dopamine D1 receptor imaging in vivo in the human brain.

Verhoeff NP, Bekier A, Beer HF, Schubiger PA, Fennema P, van Royen EA. Verhoeff NP, et al. Among authors: schubiger pa. Nucl Med Commun. 1993 Feb;14(2):137-44. doi: 10.1097/00006231-199302000-00012. Nucl Med Commun. 1993. PMID: 8429993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters